Business
‘Trust someone’: AstraZeneca boss says transparency key for vaccine – Sydney Morning Herald
The boss of global biotech firm AstraZeneca has confirmed the company is still waiting for its US trial to restart.
The pause of the trial prompted global calls for more transparency on how COVID-19 vaccines are developed.
Mr Soriot, who is also a director of CSL, said he understood the desire for that transparency but that the integrity of trials also had to be protected. “We are looking at how much transparency we can provide, considering we are in a very special set of circumstances,” he said.
Johnson & Johnson’s chief scientific officer Dr Paul Stoffels.
AstraZeneca was working with other vaccine m…
-
Noosa News24 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business22 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News20 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
Business20 hours agoThe best ASX shares to buy and forget for 10+ years